These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 11925325)

  • 21. Attentional modulation of perceptual organisation in schizophrenia.
    Kéri S; Kelemen O; Benedek G
    Cogn Neuropsychiatry; 2009 Mar; 14(2):77-86. PubMed ID: 19370433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of typical, atypical, and no antipsychotic drugs on visual contrast detection in schizophrenia.
    Chen Y; Levy DL; Sheremata S; Nakayama K; Matthysse S; Holzman PS
    Am J Psychiatry; 2003 Oct; 160(10):1795-801. PubMed ID: 14514493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dysfunction of early-stage visual processing in schizophrenia.
    Butler PD; Schechter I; Zemon V; Schwartz SG; Greenstein VC; Gordon J; Schroeder CE; Javitt DC
    Am J Psychiatry; 2001 Jul; 158(7):1126-33. PubMed ID: 11431235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A sensitizing regimen of amphetamine impairs visual attention in the 5-choice serial reaction time test: reversal by a D1 receptor agonist injected into the medial prefrontal cortex.
    Fletcher PJ; Tenn CC; Sinyard J; Rizos Z; Kapur S
    Neuropsychopharmacology; 2007 May; 32(5):1122-32. PubMed ID: 17047670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Simplification and optimization in drug therapy for patients with schizophrenia--knowledge and techniques in drug switching].
    Takeda T
    Seishin Shinkeigaku Zasshi; 2006; 108(6):624-30. PubMed ID: 16910541
    [No Abstract]   [Full Text] [Related]  

  • 26. Schizophrenia.
    Freedman R
    N Engl J Med; 2003 Oct; 349(18):1738-49. PubMed ID: 14585943
    [No Abstract]   [Full Text] [Related]  

  • 27. Caffeine modulates attention network function.
    Brunyé TT; Mahoney CR; Lieberman HR; Taylor HA
    Brain Cogn; 2010 Mar; 72(2):181-8. PubMed ID: 19733954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The late positive component of the evoked response in acute schizophrenics during a test of sustained attention.
    Pass HL; Klorman R; Salzman LF; Klein RH; Kaskey GB
    Biol Psychiatry; 1980 Feb; 15(1):9-20. PubMed ID: 7357059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The somatic component of schizophrenia: a dissociation of the goals of visual attention and bifoveal fixation?
    Korn H
    Med Hypotheses; 1999 Feb; 52(2):163-70. PubMed ID: 10340297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dissection of early bottom-up and top-down deficits during visual attention in schizophrenia.
    Neuhaus AH; Karl C; Hahn E; Trempler NR; Opgen-Rhein C; Urbanek C; Hahn C; Ta TM; Dettling M
    Clin Neurophysiol; 2011 Jan; 122(1):90-8. PubMed ID: 20609622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term but not short-term blockade of dopamine release in Drosophila impairs orientation during flight in a visual attention paradigm.
    Ye Y; Xi W; Peng Y; Wang Y; Guo A
    Eur J Neurosci; 2004 Aug; 20(4):1001-7. PubMed ID: 15305868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopamine and selective attention.
    Matthysse S
    Adv Biochem Psychopharmacol; 1977; 16():667-9. PubMed ID: 883565
    [No Abstract]   [Full Text] [Related]  

  • 33. Delayed peak latency of the mismatch negativity in schizophrenics and alcoholics.
    Kathmann N; Wagner M; Rendtorff N; Engel RR
    Biol Psychiatry; 1995 May; 37(10):754-7. PubMed ID: 7640331
    [No Abstract]   [Full Text] [Related]  

  • 34. [Visuo-perceptual processing in patients with schizophrenia treated with typical or atypical antipsychotics].
    Romera MI; Gurpegui M
    Actas Esp Psiquiatr; 2001; 29(1):19-24. PubMed ID: 11333515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuropsychology of vision.
    De Haan EH; Newcombe F
    Curr Opin Neurol Neurosurg; 1992 Feb; 5(1):65-70. PubMed ID: 1623241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacologic treatment of adolescent and child schizophrenia.
    Young CM; Findling RL
    Expert Rev Neurother; 2004 Jan; 4(1):53-60. PubMed ID: 15853615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of high doses of neuroleptics: the current situation.
    King DJ
    Int Clin Psychopharmacol; 1994; 9(2):75-8. PubMed ID: 7914527
    [No Abstract]   [Full Text] [Related]  

  • 38. Stereopsis and magnocellular sensitivity in schizophrenia.
    Skottun BC; Skoyles JR
    World J Biol Psychiatry; 2009; 10(4 Pt 3):697-701. PubMed ID: 18609415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anomalous visual experiences, negative symptoms, perceptual organization and the magnocellular pathway in schizophrenia: a shared construct?
    Kéri S; Kiss I; Kelemen O; Benedek G; Janka Z
    Psychol Med; 2005 Oct; 35(10):1445-55. PubMed ID: 16164768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are masking abnormalities in schizophrenia specific to type-B masking?
    Skottun BC; Skoyles JR
    World J Biol Psychiatry; 2009; 10(4 Pt 3):798-808. PubMed ID: 19707956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.